Article
▤Article
Ddlapiper.com·Written by:Chloe ForsterRebecca LawrenceLinzi PenmanKate Black·9 min read
The future of FemTech: Emerging trends and challenges | DLA Piper
- FemTech is at an inflection point, and improving women’s health now depends on responsible innovation, funding, data governance, and integration with health systems.
- Women’s health conditions are often underdiagnosed and poorly understood; endometriosis affects one in ten women, yet treatment has not changed in 30 years.
- Women spend about a quarter of their working lives in poorer health, making the women’s health gap a productivity and economic issue as well as a medical one.
- FemTech is expanding beyond reproductive health to include diseases that disproportionately affect women, such as cardiovascular disease, autoimmune disorders, and chronic pain.
- AI, machine learning, wearables, genomics, and robotics are expected to enable earlier detection, more personalised treatment, and more preventive care.
- The NHS Genomic Medicine Service is expected to play a major role in the next phase of FemTech and women’s health innovation.
- Early-stage FemTech faces investment hurdles because of long regulatory timelines, high upfront costs, and legal complexity.
- Investors increasingly want FemTech companies to show a clear path to integration with healthcare systems, not just technical innovation.
- FemTech depends on data, but the sector is hindered by fragmented datasets, data silos, and sensitivity around women’s health data.
Your notes
Save this item to your library to add private notes.